# Real-World Emulation of the SWEFOT Trial

> **NCT05051137** · — · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 509 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Infliximab
- **DRUG:** Sulfasalazine + Hydroxychloroquine

## Key facts

- **NCT ID:** NCT05051137
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01-12
- **Primary completion:** 2020-11-16
- **Final completion:** 2020-11-16
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05051137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05051137, "Real-World Emulation of the SWEFOT Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05051137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*